Teva's Cephalon buyout close to EU nod; Rival bidder out, Allos still in talks with Amag;

@FiercePharma: Already owing huge amounts to drugmakers, Spain shuts ERs, proposes physician pay cut - Reuters #pharma. Article |  Follow @FiercePharma

> Teva Pharmaceutical Industries ($TEVA) is on the verge of wining conditional EU approval for its buyout of U.S.-based Cephalon ($CEPH), sources tell Reuters. Report

> Allos Therapeutics ($ALTH) says it's still in talks to sell itself to Amag Pharmaceuticals ($AMAG) after a rival bidder pulled out. Item

> Wisconsin contract manufacturer Anteco Pharma is breaking ground on a $3.5 million addition to its facility in the first phase of a 5-year expansion plan. Article

> The contract manufacturing association has joined calls to cut the tax rate on repatriated foreign earnings. Story

> Aurobindo Pharma won final FDA approval for its version of the Pfizer ($PFE) CNS drug Neurontin. Report

> The U.S. Pharmacopeial Convention has teamed up with Russian regulators to help raise standards for drugs made in that country. Article

> Shaanxi Aoxing Pharmaceutical agreed to buy Shaanxi Weinan Huaren Pharmaceuticals and its portfolio of 86 drugs for $9.62 million. Item

> Young and middle-aged people with prehypertension have a much higher risk of stroke than those with normal blood pressure. Report

Biotech News

 @FierceBiotech: Roche spotlights PhI efficacy of Alzheimer's antibody. Article | Follow @FierceBiotech

 @ JohnCFierce: Glaxo R&D chief Slaoui outlines his formula for success. News | Follow @JohnCFierce

 @RyanMFierce: I saw twitter action on this fertility startup OvaScience a while ago, but @scottkirsner is first to write an article. Report | Follow @RyanMFierce

> Glaxo R&D chief Slaoui outlines his formula for success. Story

> Roche spotlights PhI efficacy of Alzheimer's antibody. Item 

> Biotech startup Cleave lands $42M A round for targeted cancer drugs. Article

Manufacturing News

> Counterfeits quantified. Story

> AZ ups emerging markets bet with $200M plant in China. Report 

> Sanofi's Viehbacher sees green lights ahead for Shantha. Article

> Kimberly-Clark program gives new life to cleanroom garb. Report

> Sen. Schumer asks FTC to probe gray market mark-ups in drug shortages. Story

> Teva, partners fined $20M in second propofol/Hep-C case. News

Biotech Research News

> Great minds collaborate on new RNAi approach to inflammation. Story

> Cloning tech used to create breakthrough stem cells for research. Article

> Diabetes science team finds a "negative regulator" for insulin secretion. Report

> Natural compound shows promise as a pathway to diabetes pill. Item

And Finally... Israeli doctors walked out en masse in a salary dispute, forcing hospitals to turn some patients away. Story

Suggested Articles

FDA researchers uncover more concerns and fears among front-line workers and minority groups about a COVID-19 vaccine.

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more. 

Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial—and moved one step closer to approval.